2002
DOI: 10.1016/s0959-8049(01)00407-5
|View full text |Cite
|
Sign up to set email alerts
|

Primary breast cancer therapy in six regions of Germany

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0
14

Year Published

2002
2002
2013
2013

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 49 publications
(33 citation statements)
references
References 37 publications
1
18
0
14
Order By: Relevance
“…Comparisons were drawn with a historic cohort on primary breast cancer therapy in six regions of Germany, which was published in 2002 and comprised a sample of N ¼ 8661 (Engel et al, 2002). The proportion of patients aged X70 years was 2425 out of 8661 (27.9%, C.I.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Comparisons were drawn with a historic cohort on primary breast cancer therapy in six regions of Germany, which was published in 2002 and comprised a sample of N ¼ 8661 (Engel et al, 2002). The proportion of patients aged X70 years was 2425 out of 8661 (27.9%, C.I.…”
Section: Resultsmentioning
confidence: 99%
“…The most simple and often found method (Engel et al, 2002) for analysing differences is collapsing the individual data points into QoL scores and comparing their means. In our case, patientreported global QoL was 66.7 (50.0 -77.1) points (median and interquartile range), mean 61.5 and standard deviation 23.2, significantly lower than doctors' judgement of patients ' global QoL,3), respectively, mean 71.0 and s.d.…”
Section: Very Goodmentioning
confidence: 99%
“…Prognostically, pure mucinous carcinomas have an excellent prognosis, but the outcome for mixed mucinous carcinomas is similar to NST tumors [15]. …”
Section: Special Subtypes Of Invasive Breast Carcinomamentioning
confidence: 99%
“…While limited data regarding treatment compliance with adjuvant endocrine therapy suggest that compliance may be an issue in women with breast cancer [12][13][14], these findings are not from prospective studies in real-life clinical settings. Furthermore, while data are available on the practice of prescribing AIs in Germany [15,16], these do not accurately capture whether the medication was actually taken correctly.…”
Section: Introductionmentioning
confidence: 99%